预测误差的比较:专用与非专用人工晶状体制造公差的比较

Comparison of prediction error: Labeled versus unlabeled intraocular lens manufacturing tolerance
2012-07-25 09:25点击:101次发表评论
作者:" Noelle S. Matta, CO, CRC, COTCorresponding au 【View at publisher】 【全球专家评论】
期刊: J CATARACT REFR SURG2011年1月3期38卷 专家评级:★★ 循证评级:B

Purpose:

To compare the prediction error between intraocular lenses (IOLs) available in 0.25 diopter (D) increments with a labeled manufacturing tolerance and IOLs available in 0.50D increments without a labeled manufacturing tolerance.

Setting:

Community-based multidisciplinary outpatient ophthalmic practices.

Design:

Comparative case series.

Methods:

Eyes with cataract had implantation of an IOL available in 0.25D increments and labeled with a manufacturing tolerance of ±0.11D (labeled group) or an IOL available in 0.50D increments without a labeled manufacturing tolerance (unlabeled group). Postoperatively, the prediction error was calculated and compared between groups.

Results:

By the SRK/T formula, the mean error of prediction after optimization was −0.03D±0.35 (SD) in the labeled group and −0.05±0.46D in the unlabeled group (P=.64). The mean absolute error of prediction was statistically significantly smaller in the labeled group (0.26±0.23D) than in the unlabeled group (0.37±0.28D) (P=.04). The mean and absolute errors were not statistically significantly different with the Holladay 1 or Hoffer Q formula. Sixty-three percent of patients in the labeled group and 43% in the unlabeled group (P=.03) were within ±0.25D of the prediction error; 84% and 69%, respectively, were within ±0.50D (P=.06).

Conclusion:

The IOLs available in 0.25D increments with a labeled manufacturing tolerance of ±0.11D increased the percentage of patients within ±0.25D of the targeted refraction to a statistically significant and clinically meaningful level compared with unlabeled IOLs available in 0.50D increments

学科代码:外科学 眼科学   关键词:预测误差的比较:专用与非专用人工晶状体制造公差的比较
来源: Eclips
Eclips介绍:Eclips由权威专家阅读世界顶级医学期刊(包括New England Journal of Medicine, The Lancet, JAMA, BMJ 等)后筛选出最顶尖的文章,并总结、分级和点评,为繁忙的临床医生提供最快、最有效的前沿医学信息,并同时提供临床医生参与点评文献和同行互动交流的学术平台。 请点击申请试用并填写联系信息,我们将每月为前100位申请者发送带有用户名、密码及网页链接的电子邮件,请您注意查收!感谢您的参与及使用! 马上访问Eclips网站http://eclips.consult.com/
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录